Why the study?
Does 15-Methyl Prostaglandin F2 Alpha cause maternal arterial desaturation in patients with uterine atony?
Does 15-Methyl Prostaglandin F2 Alpha cause maternal arterial desaturation in patients with uterine atony?
Answers are grounded in this paper and cite their sources.
The paper discusses maternal arterial desaturation associated with the use of 15-Methyl Prostaglandin F2 Alpha for uterine atony.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Hankins et al. (1989) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: